NCT02849236View on ClinicalTrials.gov

PECS I Block for Breast Subpectoral Implant Surgery

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 16, 2016

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
Pain, Postoperative
Interventions
DRUG

Ropivacaine (PECS bloc)

"Ropivacaine 3.75mg/mL~Injection of a local anesthetic between pectoral major and pectoral minor muscles"

DRUG

Placebo

20 mL saline 0.9%

Trial Locations (1)

Unknown

Hôpital Roger Salengro, CHU de Lille, Lille

All Listed Sponsors
lead

University Hospital, Lille

OTHER

NCT02849236 - PECS I Block for Breast Subpectoral Implant Surgery | Biotech Hunter | Biotech Hunter